Time to go All-In on Celsion?
Celsion (CLSN) is a great story stock. It recently announced their Phase III trial results for liver cancer will be released by the end of January 2013. This will be a top-line release of a multinational, double-blind, placebo-controlled study of primary liver cancer. The results could make or break the company as its future pipeline is dependent on ThermoDox succeeding.
This upcoming catalyst is likely to have a huge impact on the company's valuation. The company has a current market cap of $287 million, but this will likely be drastically different by the end of the month. The CEO of Celsion has stated that this liver cancer treatment will have the potential to generate yearly revenues of $1 billion.
Mastery Bottom Line
Look for a good entry point before betting the farm on CLSN. Shares could dip down to touch the 50 day MA due to some investors not wanting to risk holding through the FDA results. A $7 - $7.50 share price would provide a great buying opportunity.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Will Germany Build the Next Silicon Valley? | Financial Sense
- Futures Wipe Out Early Gains In Volatile Session As Dollar Resumes Climb; Oil Slides | ZeroHedge
- Housing Contribution To US GDP Lowest In Post-War Era | ZeroHedge
- Flows Into European Equities Reaches Feverish Pitch, Consolidation Likely Ahead | Financial Sense
- Syria "Welcomes" Larger Russia Presence | ZeroHedge
- Driverless Cars Poised to Transform Automotive Industry | Financial Sense
- Fed's Bullard: Raise Rates or Face ‘Devastating’ Bubbles | Financial Sense
The most relevant financial news and articles from the Internets
- 'The Jinx' is eerily similar to the 1998 documentary ‘The Thin Blue... | Business Insider
- 10 things you need to know before the opening bell (DIA, SPY, SPX, QQQ, CVX,... | Business Insider
- Michael Sam says 'famous' NFL players have come out to him as gay | Business Insider
- Become a modern day rockstar with the Jamstik Wireless Smart Guitar [$... | Business Insider
- Qaeda, allies seize Syria's Idlib city in blow to regime... | Business Insider
- 8 Mother's Day gifts that any mom would want this year [up to 63% off] | Business Insider
- The 16 greatest books about how to be a man | Business Insider